StockData
Zai Lab Ltd logo

Zai Lab Ltd (ZLAB) stock

ZLABNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/30421% above fair value
$23.53+0.06 (+0.26%)

Close on Nov 17, 2026Market cap $3.65BP/E –Yield –

Zai Lab pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

No pe ratio figures for Zai Lab

Zai Lab has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Zai Lab figures

See a number that looks wrong?